J Committee Member Employment Consultant Speakers Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Bene t Expert Witness Thomas M. Maddox (Chair) BJC HealthCare and Washington University School of Medicine Executive Director, Healthcare Innovation Lab; Professor of Medicine None None None None None None James L. Januzzi Jr. (Vice Chair) Harvard Medical School Hutter Family Professor of Medicine; Director, Dennis and Marilyn Barry Fellowship in Cardiology Research; Senior Cardiometabolic Faculty, Baim Institute for Clinical Research n Abbott n Roche Diagnostics* None None n Abbott* n Amgen (DSMB)* n Boehringer Ingel- heim (DSMB)* n Janssen Pharmaceu- ticals (DSMB)* n Novartis* None None Larry A. Allen University of Colorado School of Medicine Associate Professor of Medicine n Abbott n Amgen n Boston Scienti c n Novartis None None None n Janssen None Khadijah Breathett University of Arizona College of Medicine Assistant Professor of Medicine, Division of Cardiology, Advanced Heart Failure and Transplant None None None None None None Javed Butler University of Mississippi Medical Center Patrick H. Lehan Professor; Chairman, Department of Medicine n Abbott n AstraZeneca n Boehringer Ingelheim* n Eli Lilly* n Janssen* n Medtronic n Novartis* n Relypsa* n Roche Diagnostics n Janssen* n Novartis* None n Amgen (DSMB) n Bristol-Myers Squibb (DSMB) None None Leslie L. Davis University of North Carolina at Chapel Hill Associate Professor of Nursing None None None None n AANP None Gregg C. Fonarow David Geffen School of Medicine, UCLA Division of Cardiology Professor of Medicine n Abbott* n Amgen n AstraZeneca n CHF Solutions Lifesciences* n Janssen n Medtronic n Novartis* None None None n Boston Scienti c None Continued on the next page APPENDIX 1. AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (RELEVANT) 2021 UPDATE TO THE ACC EXPERT CONSENSUS DECISION PATHWAY ON OPTIMIZATION OF HEART FAILURE TREATMENT: ANSWERS TO 10 PIVOTAL QUESTIONS ABOUT HEART FAILURE WITH REDUCED EJECTION FRACTION To avoid actual, potential, or perceived con icts of interest that may arise as a result of industry relationships or personal interests among the writing committee, all members of the writing committee, as well as peer reviewers of the document, are asked to disclose all current healthcare-related relationships, including those existing 12 months before initiation of the writing effort. 